ProMetic Life Sciences Inc. – Product Pipeline Review
– Q1 2011
Reference Code: GMDHC1268CDB
Publication Date: JUN 2011
ProMetic Life Sciences Inc. – Product Pipeline Review – Q1 2011 GMDHC1268CDB / Published JUN 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied Page(1)
ProMetic Life Sciences Inc. – Product Pipeline Review
Ta b le o f Co n te n ts
Table of Contents 2
List of Tables 4
List of Figures 4
ProMetic Life Sciences Inc. Snapshot 5
ProMetic Life Sciences Inc. Overview 5
Key Information 5
Key Facts 5
ProMetic Life Sciences Inc. – Research and Development Overview 6
Key Therapeutic Areas 6
ProMetic Life Sciences Inc. – Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products – Monotherapy 10
Pipeline Products – Combination Treatment Modalities 11
ProMetic Life Sciences Inc. – Pipeline Products Glance 12
ProMetic Life Sciences Inc. Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
ProMetic Life Sciences Inc.–Early Stage Pipeline Products 14
Pre-Clinical Products/Combination Treatment Modalities 14
ProMetic Life Sciences Inc. – Drug Profiles 15
PBI-1393 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
PBI-1402 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
PBI-0110 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
PBI-0110 + Gemcitabine 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
PBI-1522 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
PBI-1607 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
PBI-1668 21
Product Description 21
ProMetic Life Sciences Inc. – Product Pipeline Review – Q1 2011 GMDHC1268CDB / Published JUN 2011
©Global Markets Direct.. This report is a licensed product and is not to be photocopied Page(2)
ProMetic Life Sciences Inc. – Product Pipeline Review
Mechanism of Action 21
R&D Progress 21
PBI-1737 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
PBI-4050 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
PBI-4419 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
PBI-4494 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
ProMetic Life Sciences Inc. – Pipeline Analysis 26
ProMetic Life Sciences Inc. – Pipeline Products by Therapeutic Class 26
ProMetic Life Sciences Inc. - Pipeline Products By Target 28
ProMetic Life Sciences Inc. – Pipeline Products by Route of Administration 29
ProMetic Life Sciences Inc. – Pipeline Products by Molecule Type 30
ProMetic Life Sciences Inc. – Recent Pipeline Updates 31
ProMetic Life Sciences Inc. - Dormant Projects 32
ProMetic Life Sciences Inc. – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Financial Deals Landscape 35
ProMetic Life Sciences Inc., Deals Volume Summary, 2004 to YTD 2011 35